Citation data

OpenCitations

Works that cite this article, indexed by OpenCitations.

12 resultsUpdated October 20, 2026
1

Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?

Hepatitis Monthly 14(11) (2014)

Mohamad Amin Pourhoseingholi; Sara Ashtari; Seyed Moayed Alavian

2

Genetic Variations in Host Factors and their Critical Role on HCV Medication

Research in Molecular Medicine 5(1) (2017)

Maryam Karkhane; Abdolrazagh Marzban; Hamed Esmaeil Lashgarian; Mohammad Reza Zali

3

A Cost-Utility Analysis of Different Antiviral Medicine Regimens in Patients With Chronic Hepatitis C Virus Genotype 1 Infection

Iranian Red Crescent Medical Journal 18(11) (2016)

Seyed Moayed Alavian; Shekoufeh Nikfar; Abbas Kebriaeezadeh; Farhad Lotfi; Ehsan Sanati; Mohsen Rezaei Hemami; Khosro Keshavarz

4

Estimation of direct medical cost related to the management of chronic hepatitis C and its complications in South Korea

Medicine 95(30) (2016)

Do Young Kim; Ki Tae Yoon; Won Kim; Jung Il Lee; Sung Hwi Hong; Danbi Lee; Jeong Won Jang; Jong Won Choi; Ilsu Kim; Yong Han Paik

5

Treatment with ledipasvir and sofosbuvir improves patient‐reported outcomes: Results from the ION‐1, ‐2, and ‐3 clinical trials

Hepatology 61(6) (2015)

Zobair M. Younossi; Maria Stepanova; Patrick Marcellin; Nezam Afdhal; Kris V. Kowdley; Stefan Zeuzem; Sharon L. Hunt

6

Financial Burden of Liver Transplant vs Resection for Hepatocellular Carcinoma

Transplantation Proceedings 51(6) (2019)

Nicholas J. Skill; James Butler; Daniel C. O’Brien; Joshua K. Kays; Chandrasekhar Avinash Kubal; Suthat Liangpunsakul; Nehal Ninad; Mary A. Maluccio

7

Hepatocellular carcinoma in Asia: Prevention strategy and planning

World Journal of Hepatology 7(12) (2015)

Sara Ashtari